BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Aricept donepezil: Phase IIIb data

A double-blind, placebo-controlled, French Phase IIIb trial in 216 patients with early AD showed that 10 mg Aricept once daily reduced the rate of hippocampal atrophy at 1 year by 45% vs. placebo...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >